Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02170389 · ClinicalTrials.gov registry record · NA
Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02170389 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 5 participants.
The verdict
NCT02170389, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This pilot clinical trial studies vaccine therapy before surgery in treating patients with kidney cancer that has not spread to nearby lymph nodes or to other parts of the body. Vaccines made from a person's tumor cells and white blood cells may help the body build an effective immune response to kill tumor cells when they are infused back into the body.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Nephrectomy
- BIOLOGICAL Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-10-14 |
| Est. Completion | 2017-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02170389
The ClinicalTrials.gov registry entry for NCT02170389 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02170389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02170389 about?
NCT02170389 is a clinical study titled "Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer". This pilot clinical trial studies vaccine therapy before surgery in treating patients with kidney cancer that has not spread to nearby lymph nodes or to other parts of the body. Vaccines made from a person's tumor cells and white blood cells may help the body build an effective immune response to ki...
What is the current status of trial NCT02170389?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2014-10-14. Estimated completion is 2017-03-17.
What interventions are being tested in trial NCT02170389?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Nephrectomy (PROCEDURE), Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02170389?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.